Use of antisecretory agents as a trial of therapy.

  • Fennerty M
  • 4


    Mendeley users who have this article in their library.
  • 8


    Citations of this article.


Dyspepsia is a common clinical condition, and its diagnostic evaluation and treatment result in the expenditure of enormous healthcare resources each year. Studies indicate that the omeprazole test is the most sensitive and cost effective test for diagnosing gastro-oesophageal reflux disease (GORD) in patients with extra-oesophageal or more "classic" symptoms suggestive of GORD. Studies also indicate that a therapeutic trial of omeprazole in patients with dyspepsia results in greater symptom improvement and lower costs than treatment with less potent acid suppression.

Author-supplied keywords

  • Anti-Ulcer Agents
  • Anti-Ulcer Agents: therapeutic use
  • Dyspepsia
  • Dyspepsia: drug therapy
  • Dyspepsia: etiology
  • Gastroesophageal Reflux
  • Gastroesophageal Reflux: complications
  • Gastroesophageal Reflux: diagnosis
  • Gastroesophageal Reflux: drug therapy
  • Humans
  • Omeprazole
  • Omeprazole: therapeutic use

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • SCOPUS: 2-s2.0-0036116757
  • ISSN: 0017-5749
  • SGR: 0036116757
  • PMID: 11953352
  • PUI: 34407474


  • M B Fennerty

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free